Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice

Disrupted bile secretion leads to liver damage characterized by inflammation, fibrosis, eventually cirrhosis, and hepatocellular cancer. As obstructive cholestasis often progresses insidiously, markers for the diagnosis and staging of the disease are urgently needed. To this end, we compiled a compr...

Full description

Saved in:
Bibliographic Details
Main Authors: Abshagen, Kerstin (Author) , Ebert, Matthias (Author) , Weng, Honglei (Author) , Dooley, Steven (Author)
Format: Article (Journal)
Language:English
Published: 20 November 2015
In: BMC systems biology
Year: 2015, Volume: 9
ISSN:1752-0509
DOI:10.1186/s12918-015-0229-0
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12918-015-0229-0
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12918-015-0229-0
Get full text
Author Notes:Kerstin Abshagen, Matthias König, Andreas Hoppe, Isabell Müller, Matthias Ebert, Honglei Weng, Herrmann-Georg Holzhütter, Ulrich M. Zanger, Johannes Bode, Brigitte Vollmar, Maria Thomas and Steven Dooley
Description
Summary:Disrupted bile secretion leads to liver damage characterized by inflammation, fibrosis, eventually cirrhosis, and hepatocellular cancer. As obstructive cholestasis often progresses insidiously, markers for the diagnosis and staging of the disease are urgently needed. To this end, we compiled a comprehensive data set of serum markers, histological parameters and transcript profiles at 8 time points of disease progression after bile duct ligation (BDL) in mice, aiming at identifying a set of parameters that could be used as robust biomarkers for transition of different disease progression phases.
Item Description:Gesehen am 18.12.2017
Physical Description:Online Resource
ISSN:1752-0509
DOI:10.1186/s12918-015-0229-0